Literature DB >> 1375194

Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

H M Kuhn1, L Brade, B J Appelmelk, S Kusumoto, E T Rietschel, H Brade.   

Abstract

A series of monoclonal antibodies directed against lipid A was characterized by using synthetic lipid A analogs and partial structures. These compounds vary in phosphate substitution, acylation pattern (type, number, and distribution of fatty acids), and, in the case of monosaccharides, in their backbone glycosyl residue. The monoclonal antibodies tested could be subdivided into five groups according to their reactivity patterns. One group reacted exclusively with 1,4'-bisphosphoryl lipid A, and a second also reacted with 4'-monophosphoryl lipid A. Two further groups recognized either 4-phosphoryl or 1-phosphoryl monosaccharide partial structures of lipid A. The fifth group reacted with 4-phosphoryl monosaccharide structures and with phosphate-free compounds. Antibodies reactive with monosaccharide structures also recognized their epitopes in corresponding phosphorylated disaccharide compounds. Both groups of monosaccharide and monophosphoryl lipid A-recognizing antibodies have access to their epitopes in bisphosphoryl compounds as well. Because of this unidirectional reactivity with more complex structures, the various specificities cannot be distinguished by using bisphosphoryl lipid A (e.g., Escherichia coli lipid A) as a test antigen. The epitopes recognized by the various monoclonal antibodies all reside in the hydrophilic backbone of lipid A, and there was no indication that fatty acids were part of the epitopes recognized. Nevertheless, the reactivities of compounds in the different test systems are strongly influenced by their acylation patterns; i.e., acyl groups may modulate the exposure of lipid A epitopes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375194      PMCID: PMC257144          DOI: 10.1128/iai.60.6.2201-2210.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies.

Authors:  R Girard; R Chaby
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

2.  An immunoprotective monoclonal antibody to lipopolysaccharide.

Authors:  T N Kirkland; E J Ziegler
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

3.  Endotoxic properties of synthetic pentaacyl lipid A precursor Ib and a structural isomer.

Authors:  E T Rietschel; L Brade; U Schade; C Galanos; M Freudenberg; O Lüderitz; S Kusumoto; T Shiba
Journal:  Eur J Biochem       Date:  1987-11-16

4.  Isolation and structural analysis of two lipid A precursors from a KDO deficient mutant of Salmonella typhimurium differing in their hexadecanoic acid content.

Authors:  T Hansen-Hagge; V Lehmann; U Seydel; B Lindner; U Zähringer
Journal:  Arch Microbiol       Date:  1985-05       Impact factor: 2.552

5.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.

Authors:  T Calandra; M P Glauser; J Schellekens; J Verhoef
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

7.  Synthetic Salmonella-type lipid A antigen with high serological specificity.

Authors:  N Kasai; S Arata; J Mashimo; K Okuda; Y Aihara; S Kotani; H Takada; T Shiba; S Kusumoto; M Imoto
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.

Authors:  N N Teng; H S Kaplan; J M Hebert; C Moore; H Douglas; A Wunderlich; A I Braude
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.

Authors:  M F Salles; E Mandine; R Zalisz; M Guenounou; P Smets
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

10.  Immunogenic properties of lipid A.

Authors:  C Galanos; M A Freudenberg; F Jay; D Nerkar; K Veleva; H Brade; W Strittmatter
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug
View more
  30 in total

1.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic.

Authors:  Roberto Cighetti; Carlotta Ciaramelli; Stefania Enza Sestito; Ivan Zanoni; Łukasz Kubik; Ana Ardá-Freire; Valentina Calabrese; Francesca Granucci; Roman Jerala; Sonsoles Martín-Santamaría; Jesus Jiménez-Barbero; Francesco Peri
Journal:  Chembiochem       Date:  2013-12-12       Impact factor: 3.164

4.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Authors:  B J Appelmelk; Y Q An; B G Thijs; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase I in lipopolysaccharide biosynthesis.

Authors:  Sabine Gronow; Werner Brabetz; Buko Lindner; Helmut Brade
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

7.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.

Authors:  J Schletter; H Brade; L Brade; C Krüger; H Loppnow; S Kusumoto; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies.

Authors:  L Brade; O Holst; H Brade
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock.

Authors:  P Gallay; D Heumann; D Le Roy; C Barras; M P Glauser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.